The current PE ratio for Collegium Pharmaceutical stock as of Jul 26, 2024 is 12.84. This is calculated based on the current EPS of $2.81 and the stock price of $36.08 per share.
The average historical PE ratio of Collegium Pharmaceutical for the last four years is 24.78. The current PE ratio of 12.84 is 48% below the historical average. Over the past four years, COLL's PE ratio was at its highest in the Sep 2023 quarter at 85.96, when the stock price was $22.35 and the EPS was $0.26. The lowest value was in the Sep 2021 quarter, when it reached 6.71 with a price of $19.74 and an EPS of $2.94.
Maximum annual decrease: -64.52% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 21.52 | N/A |
| 2022 | N/A | N/A |
| 2021 | 9.11 | -64.52% |
| 2020 | 25.68 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
Currently, COLL's PE ratio is below the 3 and 5-year averages.
COLL's PE ratio is lower than its peer stock UTHR.
| Stock name | PE ratio | Market cap |
|---|---|---|
| COLL Collegium Pharmaceutical Inc | 12.84 | $1.18B |
| UTHR UNITED THERAPEUTICS Corp | 15.13 | $15B |
| LPCN Lipocine Inc | N/A | $29.47M |
| SUPN Supernus Pharmaceuticals Inc | N/A | $1.69B |
COLL stock has a price to earnings ratio of 12.84 as of Jul 26, 2024.
The average PE ratio for COLL stock over the past 3 years is 25.66.
The average PE ratio for COLL stock over the past 5 years is 24.78.
In the last four years, the Sep 2023 quarter recorded the highest quarterly PE ratio at 85.96.
The current price to earnings ratio of COLL is 48% lower than the 4-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jul 26, 2024), Collegium Pharmaceutical's stock price is $36.08. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.81. Therefore, Collegium Pharmaceutical's P/E ratio for today is 12.84. PE RATIO(12.84) = STOCK PRICE($36.08) / TTM EPS($2.81)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.